Skip to content

EvaLuating negAtive pressUre Wound theRapy in brEast coNserving Surgery

EvaLuating negAtive pressUre Wound theRapy in brEast coNserving Surgery

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05509829
Acronym
LAUREN
Enrollment
300
Registered
2022-08-22
Start date
2023-05-01
Completion date
2023-12-01
Last updated
2023-07-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer, Seroma, Wound Complication

Brief summary

Negative pressure wound therapy (NPWT) could improve surgical outcomes and reduce complications like SSI, wound dehiscence and seroma in closed surgical wounds. To date, NPWT was not evaluated in patients undergoing breast conserving surgery without direct reconstruction.Therefore, the aim of this trial is to evaluate the feasibility of NPWT after surgery and its effects on postoperative complications.

Detailed description

Rationale: Negative pressure wound therapy (NPWT) could improve surgical outcomes and reduce complications like SSI, wound dehiscence and seroma in closed surgical wounds. Complication rate after breast conserving surgery for breast cancer is 2-17%, surgical site infections (SSI) being the most common. To date, NPWT was not evaluated in patients undergoing breast conserving surgery without direct reconstruction. Therefore, in this trial, the aim is to evaluate the feasibility of NPWT after breast conserving surgery and its effects on postoperative complications. Objective and study parameters: Primary objective is to compare surgical site complications in patients with and without NPWT. Secondary objective is to assess the number of re-interventions, unplanned visits and pain scores. Study design: A prospective cohort of 150 patients will be compared to a retrospective cohort of 150 patients. Study population: Breast cancer patients undergoing breast conserving surgery with or without sentinel lymph node biopsy. Intervention (if applicable): Negative pressure wound therapy. Nature and extent of the burden and risks associated with participation, benefit and group relatedness: When participating in this study, patients will need to pay at least one extra visit to the hospital, possibly two if this cannot be combined with the standard postoperative visits. In addition, patients will need to have a device with them for 14 days after surgery. This device is connected to the wound dressing. All wound dressings may cause irritation or an allergic reaction. This risk is not higher than when receiving standard wound dressing, but it is something to take into consideration. Patients participating in this study may benefit from NPWT regarding the postoperative complication rate.

Interventions

DEVICENegative pressure wound therapy

Negative pressure wound therapy using PICO14.

Sponsors

Zuyderland Medisch Centrum
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

150 patients of the prospectively included cohort will undergo NPWT. 150 patients of the retrospective cohort are used as a control group.

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Eighteen years or older. * Female sex. * Indication for breast conserving surgery, with or without sentinel lymph node biopsy.

Exclusion criteria

* Undergoing mastectomy or modified radical mastectomy. * Undergoing direct breast reconstruction. * Patients with a pacemaker, intra cardiac defibrillator (ICD) or other medical device in the proximity of the wound area, due to the magnet in the PICO® device. * Unable to comprehend implications and extent of the study and/or unable to sign for informed consent. * Participation in another breast cancer surgery related clinical trial.

Design outcomes

Primary

MeasureTime frameDescription
Surgical complications3 months after surgeryNumber of surgical complications, including clinically significant seroma, surgical site infections, wound dehiscence or wound necrosis.

Secondary

MeasureTime frameDescription
Need of re-intervention3 months after surgeryNumber of patients who were in need of re-intervention(s) due to the previously mentioned surgical complications
Number of unscheduled visits to the emergency department or outpatient clinic3 months after surgeryNumber of unscheduled visits to the emergency department or outpatient clinic
Pain scores during NPWTone week after surgeryA numeric rating score will be asked to all patients receiving NPWT.

Countries

Netherlands

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026